Simplifying Global Compliance
FDA Clarifies Approval Pathways for Applications in New Draft Guidance
In a new draft guidance, the FDA describes which abbreviated approval pathways are available for ANDAs and 505(b)(2) applications.
To View This Article:
Subscribe To Generic Line
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing